Caplin Point gets nod for investment of up to $7 million in step down subsidiary

07 Aug 2018 Evaluate

Caplin Point Laboratories has received an approval for an investment in a step down subsidiary at El Salvador up to a limit of $7 million in Ordinary Shares and/ or Debt by its Wholly Owned Subsidiary  i.e. Caplin Point Far East. The Board of Directors of the company at their meeting held on August 06, 2018, approved the same.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1882.90 -35.25 (-1.84%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×